국가: 오스트레일리아
언어: 영어
출처: Department of Health (Therapeutic Goods Administration)
moxonidine
Lupin Australia Pty Limited
Registered
Moxonidine generichealth cmi v1.0 1 MOXONIDINE GENERICHEALTH TABLETS _moxonidine_ _ _ CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Moxonidine generichealth. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Moxonidine generichealth against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICATION. You may want to read it again. WHAT MOXONIDINE GENERICHEALTH IS USED FOR The name of your medicine is Moxonidine generichealth, which is also known as moxonidine. Moxonidine generichealth lowers high blood pressure, which doctors call hypertension. There are usually no symptoms of hypertension. The only way of knowing if you have hypertension is to have your blood pressure checked regularly. If high blood pressure is not treated it can lead to serious health problems, including stroke, heart disease and kidney failure. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY IT HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed Moxonidine generichealth for another use. This medicine is only available with a doctor's prescription. This medicine is not addictive. BEFORE YOU TAKE MOXONIDINE GENERICHEALTH _WHEN YOU MUST NOT TAKE IT_ DO NOT TAKE MOXONIDINE GENERICHEALTH IF YOU HAVE AN ALLERGY TO: • ANY MEDICINE CONTAINING MOXONIDINE • ANY OF THE INGREDIENTS LISTED AT THE END OF THIS LEAFLET Some symptoms of an allergic reaction include skin rash, itching, shortness of breath or swelling of the face, lips or tongue, which may cause difficulty breathing. DO NOT TAKE THIS MEDICINE IF YOU ARE PREGNANT OR THINK YOU MAY BE PREGNANT. DO NOT GIVE MOXONIDINE GENERICHEALTH TO A CHILD UNDER THE AGE OF 16 YEARS. Safety and effectiveness in children younger than 16 years have not been established. DO NOT 전체 문서 읽기